These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17129966)

  • 41. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
    Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
    Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
    Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine.
    Beck BR; Hatz C; Brönnimann R; Herzog C
    Clin Infect Dis; 2003 Nov; 37(9):e126-8. PubMed ID: 14557982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children.
    Mitra M; Shah N; Faridi M; Ghosh A; Sankaranarayanan VS; Aggarwal A; Chatterjee S; Bhattacharyya N; Kadhe G; Vishnoi G; Mane A
    Hum Vaccin Immunother; 2015; 11(5):1147-52. PubMed ID: 26018443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The investigation on the safety and immunogenicity of inactived hepatitis A vaccine AVAXIM].
    Huang G; Wan Z; Li R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):287-8. PubMed ID: 11860802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epaxal: a virosomal vaccine to prevent hepatitis A infection.
    Bovier PA
    Expert Rev Vaccines; 2008 Oct; 7(8):1141-50. PubMed ID: 18844588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.
    Hammitt LL; Bulkow L; Hennessy TW; Zanis C; Snowball M; Williams JL; Bell BP; McMahon BJ
    J Infect Dis; 2008 Dec; 198(12):1776-82. PubMed ID: 18976095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Primary study on immunologic effect of live attenuated hepatitis A vaccine (H2 strain) after booster dose].
    Wang X; Ma J; Zhang Y; Zhang Y; Han C; Xing Z; Chen J; Zhang Y; Zhao S; Gu H; Xu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):124-7. PubMed ID: 11860772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program.
    Zhuang FC; Qian W; Mao ZA; Gong YP; Jiang Q; Jiang LM; Chen NL; Chai SA; Mao JS
    Chin Med J (Engl); 2005 Nov; 118(22):1851-6. PubMed ID: 16313838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.
    Olivier C; Belohradsky BH; Stojanov S; Bonnet E; Petersen G; Liese JG
    Vaccine; 2008 Jun; 26(25):3142-52. PubMed ID: 18502545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine.
    Stojanov S; Liese JG; Belohradsky BH; Vandermeulen C; Hoppenbrouwers K; Van der Wielen M; Van Damme P; Georges B; Dupuy M; Scemama M; Watson M; Fiquet A; Stek JE; Golm GT; Schödel FP; Kuter BJ;
    Vaccine; 2007 Oct; 25(43):7549-58. PubMed ID: 17905486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users.
    Quaglio G; Pajusco B; Civitelli P; Migliozzi S; Des Jarlais DC; Romanò L; Lechi A; Mezzelani P; Lugoboni F
    Drug Alcohol Depend; 2004 Apr; 74(1):85-8. PubMed ID: 15072811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decline of maternal hepatitis A virus antibody levels in infants.
    De Silvestri A; Avanzini MA; Terulla V; Zucca S; Polatti F; Belloni C
    Acta Paediatr; 2002; 91(8):882-4. PubMed ID: 12222709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
    Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
    Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants.
    Bavdekar SB; Maiya PP; Subba Rao SD; Datta SK; Bock HL
    Indian Pediatr; 2007 Jul; 44(7):505-10. PubMed ID: 17684303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines.
    Prymula R; Chlibek R; Splino M; Kaliskova E; Kohl I; Lommel P; Schuerman L
    Vaccine; 2008 Aug; 26(35):4563-70. PubMed ID: 18602724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.